<DOC>
	<DOCNO>NCT02192229</DOCNO>
	<brief_summary>Abstract : The main objective propose study examine Safety Efficacy Evaluation Dose Regimen Vitamin D 50,000 IU ( Biodal ) tablet supplementation treatment population vitamin D deficiency . A randomized , double-blind placebo , Parallel design compare vitamin D Placebo conduct 60 Healthy male females vitamin D deficiency , age 18 49 year attend rehabilitation clinic Jordan University Hospital .Participants meet inclusion criterion ask sign inform witnessed consent form . Results obtain expected assess safety efficacy dose regimen use study per Biodal SmPC . This study also contribute global body knowledge field . The major finding generate study could open certain avenue research association status vitamin D serum .</brief_summary>
	<brief_title>Efficacy Dose Regimen Oral Vitamin D 50,000 IU Treatment Vitamin D Deficiency</brief_title>
	<detailed_description>The study design prospective randomize double blind parallel design compare Vitamin D Placebo . This study conduct Jordan University Hospital ( JUH ) . The participant Healthy male females vitamin D deficiency ( 18 49 year old ) . All eligible male female agree participate study sign inform witnessed consent form begin study . The expected duration participant participation around 120 day number visit participant 6 visit divide follow ; first visit 7 day initiation trial ( screening period ) , second day zero treatment period , third day 30 , fourth day 60 , fifth day 90 sixth last visit day 104 ( 14 day last treatment ) . Therefore treatment period 90 day post treatment follow period 14 day .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Inclusion criterion : Subject willing able give voluntary inform consent participation study . Ethnic group ( Caucasian ) . Healthy male female age 18 49 year old . Normal weight ( BMI 18.525kg/m2 ) . Physical examination assess accepted attend physician . Systolic blood pressure within normal range ( 90140 ) mmHg . Diastolic blood pressure within normal range ( 6090 ) mmHg . Heart rate within normal range ( 60100 beats/min ) . Oral body temperature within normal range ( 35.9 37.6 CÂº ) . Diagnosed vitamin D deficiency 25OH Vitamin D level &lt; 20ng/ml . All laboratory test include : Urine analysis , Hematology ( Hb , Packed Cell Volume , Red Blood Cell , Mean Corpuscular Hemoglobin , Mean Corpuscular Hemoglobin Concentration , Mea Corpuscular Volume , Leukocytes , Lymphocytes , Eosinophils , Basophils , Monocytes , Neutrophils , Platelet count ) , Kidney function test , Liver function test , Virology , Clinical chemistry , Ca , Mg , PO4 , PTH , Alkaline Phosphatase pregnancy test marry female , result within normal reference range . Able willing comply study requirement . Exclusion Criteria The subject may enter study ANY follow apply : Female subject pregnant , lactate plan pregnancy course study . Ethnic group non Caucasian . Males Females age &lt; 18 &gt; 49 year old . Underweight , overweight obese Females male Males Females diagnose diabetes , hypothyroidism , hyperthyroidism , liver disease , renal dysfunction , cardiovascular disease include hypertension , androgensecreting tumor , Cushing syndrome , congenital adrenal hyperplasia , hyperprolactinemia , and/or virilism . Known history presence food allergy intolerance ( e.g dairy product gluten contain food ) , know condition could interfere absorption , distribution , metabolism execration drug . History drug alcohol abuse , smoke 10 cigarette ( equivalent ) per day . Subjects take medication know affect metabolic parameter , metformin corticosteroid drug , vitamin D calcium . Participation another clinical bioequivalence study within 90 day prior start study period . Subjects abnormal ECG . Subjects abnormal laboratory result except 25 OHCholecalciferol level .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>